IBDEI3BT ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,2071,0)
 ;;=HUMERUS/SHOULDER FRACTURE^11^155
 ;;^UTILITY(U,$J,358.4,2072,0)
 ;;=TIBIA/FIBULA FRACTURE^19^155
 ;;^UTILITY(U,$J,358.4,2073,0)
 ;;=SPINE FRACTURE^16^155
 ;;^UTILITY(U,$J,358.4,2074,0)
 ;;=WRIST/FOREARM FRACTURE^20^155
 ;;^UTILITY(U,$J,358.4,2075,0)
 ;;=OTHER FRACTURE^14^155
 ;;^UTILITY(U,$J,358.4,2076,0)
 ;;=PAIN^15^155
 ;;^UTILITY(U,$J,358.4,2077,0)
 ;;=SPINAL CONDITIONS^17^155
 ;;^UTILITY(U,$J,358.4,2078,0)
 ;;=SYMPTOMS^18^155
 ;;^UTILITY(U,$J,358.4,2079,0)
 ;;=FALLS^6^155
 ;;^UTILITY(U,$J,358.4,2080,0)
 ;;=NERVES^13^155
 ;;^UTILITY(U,$J,358.4,2081,0)
 ;;=VACCINATIONS^14^156
 ;;^UTILITY(U,$J,358.4,2082,0)
 ;;=INJECTION^7^156
 ;;^UTILITY(U,$J,358.4,2083,0)
 ;;=EDUCATION/TRAINING^3^156
 ;;^UTILITY(U,$J,358.4,2084,0)
 ;;=COUNSELING^2^156
 ;;^UTILITY(U,$J,358.4,2085,0)
 ;;=EVALUATIONS^4^156
 ;;^UTILITY(U,$J,358.4,2086,0)
 ;;=SPINAL INJECTION CODES^10^156
 ;;^UTILITY(U,$J,358.4,2087,0)
 ;;=SUPPLIES^11^156
 ;;^UTILITY(U,$J,358.4,2088,0)
 ;;=TREATMENT PROCEDURES^12^156
 ;;^UTILITY(U,$J,358.4,2089,0)
 ;;=TRIGGER POINT INJECTIONS^13^156
 ;;^UTILITY(U,$J,358.4,2090,0)
 ;;=HOME VISIT-ESTABLISHED PT^5^156
 ;;^UTILITY(U,$J,358.4,2091,0)
 ;;=HOME VISIT-NEW PT^6^156
 ;;^UTILITY(U,$J,358.4,2092,0)
 ;;=ACUPUNCTURE^1^156
 ;;^UTILITY(U,$J,358.4,2093,0)
 ;;=NAILS^9^156
 ;;^UTILITY(U,$J,358.4,2094,0)
 ;;=INTRATHECAL BACLOFED PUMP REFILL/ADJ^8^156
 ;;^UTILITY(U,$J,358.4,2095,0)
 ;;=NEW PT-OFFICE^3^157
 ;;^UTILITY(U,$J,358.4,2096,0)
 ;;=ESTABLISHED PT-OFFICE^1^157
 ;;^UTILITY(U,$J,358.4,2097,0)
 ;;=CONSULTATIONS^5^157
 ;;^UTILITY(U,$J,358.4,2098,0)
 ;;=CARDIOVASCULAR^2^158
 ;;^UTILITY(U,$J,358.4,2099,0)
 ;;=EXTERNAL CAUSES (SECONDARY DX ONLY)^3^158
 ;;^UTILITY(U,$J,358.4,2100,0)
 ;;=MENTAL HEALTH^4^158
 ;;^UTILITY(U,$J,358.4,2101,0)
 ;;=MUSCULOSKELETAL^5^158
 ;;^UTILITY(U,$J,358.4,2102,0)
 ;;=NEPHRO/GU/GI^6^158
 ;;^UTILITY(U,$J,358.4,2103,0)
 ;;=PARAPLEGIA^8^158
 ;;^UTILITY(U,$J,358.4,2104,0)
 ;;=QUADRAPLEGIA^9^158
 ;;^UTILITY(U,$J,358.4,2105,0)
 ;;=ULCERS^13^158
 ;;^UTILITY(U,$J,358.4,2106,0)
 ;;=OTHER HEALTH STATUS FACTORS^7^158
 ;;^UTILITY(U,$J,358.4,2107,0)
 ;;=COMMON DIAGNOSES^1^158
 ;;^UTILITY(U,$J,358.4,2108,0)
 ;;=SUICIDAL IDEATIONS/ATTEMPTS^12^158
 ;;^UTILITY(U,$J,358.4,2109,0)
 ;;=SPORT PARTICIPATION^11^158
 ;;^UTILITY(U,$J,358.4,2110,0)
 ;;=SPASM OF MUSCLE (SPASTICITY)^10^158
 ;;^UTILITY(U,$J,358.4,2111,0)
 ;;=GROUP TREATMENT^5^159
 ;;^UTILITY(U,$J,358.4,2112,0)
 ;;=VOICE PROSTHESES^12^159
 ;;^UTILITY(U,$J,358.4,2113,0)
 ;;=AAC DEVICES^1^159
 ;;^UTILITY(U,$J,358.4,2114,0)
 ;;=OTHER PROCEDURES^8^159
 ;;^UTILITY(U,$J,358.4,2115,0)
 ;;=LARYNGOSCOPY PROCEDURES^6^159
 ;;^UTILITY(U,$J,358.4,2116,0)
 ;;=NASOPHARYNGOSCOPY^7^159
 ;;^UTILITY(U,$J,358.4,2117,0)
 ;;=DYSPHAGIA EVALUATION^2^159
 ;;^UTILITY(U,$J,358.4,2118,0)
 ;;=SPECIAL OTORHINOLARYNGOLOGIC SERVICES^11^159
 ;;^UTILITY(U,$J,358.4,2119,0)
 ;;=SCREENING^10^159
 ;;^UTILITY(U,$J,358.4,2120,0)
 ;;=EDUCATION^3^159
 ;;^UTILITY(U,$J,358.4,2121,0)
 ;;=FITTING/ORIENTATION DEVICE^4^159
 ;;^UTILITY(U,$J,358.4,2122,0)
 ;;=SPEECH LANGUAGE PATHOLOGY^9^159
 ;;^UTILITY(U,$J,358.4,2123,0)
 ;;=DEVELOPMENTAL DISORDERS^1^160
 ;;^UTILITY(U,$J,358.4,2124,0)
 ;;=LATE EFFECTS OF CEREBROVASCULAR DISEASE^2^160
 ;;^UTILITY(U,$J,358.4,2125,0)
 ;;=VOCAL FOLD DISORDERS^6^160
 ;;^UTILITY(U,$J,358.4,2126,0)
 ;;=SWALLOWING DISORDERS^5^160
 ;;^UTILITY(U,$J,358.4,2127,0)
 ;;=SPEECH DISORDERS^4^160
